Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis.
Adrià JuanolaAnn Thu MaKoos de WitKohilan GananandanOlivier RouxGiacomo ZaccheriniCesar JiménezMarta TononCristina SoléClara VillasecaFrank E UschnerIsabel GrauperaElisa PoseMaria José MoretaDaniela CampionUlrich BeuersRajeshawar P MookerjeeClaire FrancozFrancois DurandVictor VargasSalvatore PianoSonia AlonsoJonel TrebickaWim LalemanSumeet K AsraniGerman SorianoCarlo AlessandriaMiquel Serra-BurrielManuel Morales-RuizFerràn TorresAndrew S AllegrettiAleksander KragPaolo CaraceniHugh WatsonJuan G AbraldesElsa SolàPatrick S KamathFasiha KanwalPere Ginèsnull nullPublished in: Gut (2023)
Novel biomarkers, including IL-6, uNGAL and copeptin, can probably improve prognostication of patients with decompensated cirrhosis compared with MELD alone.
Keyphrases